EdgarLookup
SC 13D/A

AMENDMENT NO. 7 TO SCHEDULE 13D

Company
Altamira Therapeutics Ltd.
Filed
December 7, 2020
Accession Number
0001213900-20-041297
View Document ↗ View on SEC.gov ↗